Fol. Biol. 2008, 54, 81-87

https://doi.org/10.14712/fb2008054030081

T Cells in the Pathogenesis of ANCA-Associated Vasculitis: Current Knowledge

Zdenka Hrušková1,2, H. Marečková2, Z. Říhová1, R. Ryšavá1, E. Jančová1, M. Merta1, V. Tesař1

1Charles University in Prague, First Faculty of Medicine and General Teaching Hospital, Department of Nephrology, Prague, Czech Republic
2Charles University in Prague, First Faculty of Medicine and General Teaching Hospital, Institute of Immunology and Microbiology, Prague, Czech Republic

Received November 2007
Accepted March 2008

References

1. Abdulahad, W. H., Stegeman, C. A., Limburg, P. C., Kallenberg, C. G. (2007a) CD4-positive effector memory T cells participate in disease expression in ANCA-associated vasculitis. Ann. N. Y. Acad. Sci. 1107, 22-31. <https://doi.org/10.1196/annals.1381.003>
2. Abdulahad, W. H., Stegeman, C. A., van der Geld, Y. M., Doornbos-van der Meer, B., Limburg, P. C., Kallenberg, C. G. (2007b) Functional defect of circulating regulatory CD4+ T cells in patients with Wegener’s granulomatosis in remission. Arthritis Rheum. 56, 2080-2091. <https://doi.org/10.1002/art.22692>
3. Balding, C. E. J., Howie, A. J., Drake-Lee, A. B., Savage, C. O. S. (2001) Th2 dominance in nasal mucosa in patients with Wegener’s granulomatosis. Clin. Exp. Immunol. 125, 332-339. <https://doi.org/10.1046/j.1365-2249.2001.125002332.x>
4. Ballieux, B. E., van der Burg, S. H., Hagen, E. C., van der Woude, F. J., Melief, C. J., Daha, M. R. (1995) Cell-mediated autoimmunity in patients with Wegener’s granulomatosis (WG). Clin. Exp. Immunol. 100, 186-193. <https://doi.org/10.1111/j.1365-2249.1995.tb03651.x>
5. Beeton, C., Wulff, H., Standifer, N. E., Azam, P., Mullen, K.M., Pennington, M.W., Kolski-Andreaco, A., Wei, E., Grino, A., Counts, D. R., Wang, P. H., LeeHealey, C. J., S Andrews, B., Sankaranarayanan, A., Homerick, D., Roeck, W. W., Tehranzadeh, J., Stanhope, K. L., Zimin, P., Havel, P. J., Griffey, S., Knaus, H. G., Nepom, G. T., Gutman, G. A., Calabresi, P. A., Chandy, K. G. (2006) Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc. Natl. Acad. Sci. USA 103, 17414-17419. <https://doi.org/10.1073/pnas.0605136103>
6. Bosch, X., Gilabert, A., Font, J. (2006) Antineutrophil cytoplasmic antibodies. Lancet 368, 404-418. <https://doi.org/10.1016/S0140-6736(06)69114-9>
7. Brouwer, E., Cohen Tervaert, J. W., Horst, G., Huitema, M. G., van der Giessen, M., Limburg, P. C., Kallenberg, C. G. (1991) Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener’s granulomatosis and clinically related disorders. Clin. Exp. Immunol. 83, 379-386. <https://doi.org/10.1111/j.1365-2249.1991.tb05647.x>
8. Brouwer, E., Stegeman, C. A., Huitema, M. G., Limburg, P. C., Kallenberg, C. G. (1994) T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener’s granulomatosis (WG). Clin. Exp. Immunol. 98, 448-453. <https://doi.org/10.1111/j.1365-2249.1994.tb05511.x>
9. Crispin, J. C., Martinez, A., Alcocer-Varela, J. (2003) Quantification of regulatory T cells in patients with systemic lupus erythematosus. J. Autoimmun. 21, 273-276. <https://doi.org/10.1016/S0896-8411(03)00121-5>
10. Csernok, E., Trabandt, A., Muller, A., Wang, G. C., Moosig, F., Paulsen, J., Schnabel, A., Gross, W. L. (1999) Cytokine profiles in Wegener’s granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum. 42, 742-750. <https://doi.org/10.1002/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I>
11. Csernok, E., Ai, M., Gross, W. L., Wicklein, D., Petersen, A., Lindner, B., Lamprecht, P., Holle, J. U., Hellmich, B. (2006) Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood 107, 4440-4448. <https://doi.org/10.1182/blood-2005-05-1875>
12. Cunningham, M. A., Huang, X. R., Dowling, J. P., Tipping, P. G., Holdsworth, S. R. (1999) Prominence of cell-mediated immunity effectors in “pauci-immune” glomerulonephritis. J. Am. Soc. Nephrol. 10, 499-506. <https://doi.org/10.1681/ASN.V103499>
13. Del Prete, G. (1998) The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int. Rev. Immunol. 16, 427-455. <https://doi.org/10.3109/08830189809043004>
14. Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D.A., Mauri, C. (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J. Exp. Med. 200, 277-285. <https://doi.org/10.1084/jem.20040165>
15. Gephardt, G. N., Ahmad, M., Tubbs, R. R. (1983) Pulmonary vasculitis (Wegener’s granulomatosis). Immunohistochemical study of T and B cell markers. Am. J. Med. 74, 700-704. <https://doi.org/10.1016/0002-9343(83)91030-6>
16. Giscombe, R., Nityanand, S., Lewin, N., Grunewald, J., Lefvert, A. K. (1998) Expanded T cell populations in patients with Wegener’s granulomatosis: characteristics and correlates with disease activity. J. Clin. Immunol. 18, 404-413. <https://doi.org/10.1023/A:1023230722874>
17. Giscombe, R., Wang, X. B., Kakoulidou, M., Lefvert, A. K. (2006) Characterization of the expanded T-cell populations in patients with Wegener’s granulomatosis. J. Intern. Med. 260, 224-230. <https://doi.org/10.1111/j.1365-2796.2006.01688.x>
18. Griffith, M. E., Coulthart, A., Pusey, C. D. (1996) T cell responses to myeloperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis. Clin. Exp. Immunol. 103, 253-258. <https://doi.org/10.1046/j.1365-2249.1996.d01-629.x>
19. Grunewald, J., Halapi, E., Wahlstrom, J., Giscombe, R., Nityanand, S., Sanjeevi, C., Lefvert, A. K. (1998) T-cell expansions with conserved T-cell receptor β chain motifs in the peripheral blood of HLA-DRB1*0401 positive patients with necrotizing vasculitis. Blood 92, 3737-3744. <https://doi.org/10.1182/blood.V92.10.3737>
20. Huang, X. R, Holdsworth, S. R, Tipping, P. G. (1994) Evidence for delayed type hypersensitivity mechanisms in glomerular crescentic formation. Kidney Int. 46, 69-78. <https://doi.org/10.1038/ki.1994.245>
21. Jagiello, P., Gencik, M., Arning, L., Wieczorek, S., Kunstmann, E., Csernok, E., Gross, W. L., Epplen, J. T. (2004) New genomic region for Wegener’s granulomatosis as revealed by an extended association screen with 202 apoptosis-related genes. Hum. Genet. 114, 468-477. <https://doi.org/10.1007/s00439-004-1092-z>
22. Jagiello, P., Aries, P., Arning, L., Wagenleiter, S. E, Csernok, E., Hellmich, B., Gross, W. L, Epplen, J. T. (2005) The PTPN22 620W allele is a risk factor for Wegener’s granulomatosis. Arthritis Rheum. 52, 4039-4043. <https://doi.org/10.1002/art.21487>
23. Jennette, J. C, Falk, R. J. (1997) Small-vessel vasculitis. N. Engl. J. Med. 337, 1512-1523. <https://doi.org/10.1056/NEJM199711203372106>
24. Kälsch, A. I, van der Woude, F. J., Yard, B. A. (2005) The role of T lymphocytes in ANCA associated vasculitis: neglected or revisited? Clin. Nephrol. 64, 471-474. <https://doi.org/10.5414/CNP64471>
25. Kiene, M., Csernok, E., Müller, A., Metzler, C., Trabandt, A., Gross, W. L. (2001) Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome. Arthritis Rheum. 44, 469-473. <https://doi.org/10.1002/1529-0131(200102)44:2<469::AID-ANR66>3.0.CO;2-0>
26. King, W. J., Brooks, C. J., Holder, R., Hughes, P., Adu, D., Savage, C. O. S. (1998) T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission. Clin. Exp. Immunol. 112, 539-546. <https://doi.org/10.1046/j.1365-2249.1998.00615.x>
27. Komocsi, A., Lamprecht, P., Csernok, E., Mueller, A., Holl-Ulrich, K., Seitzer, U., Moosig, F., Schnabel, A., Gross, W. L. (2002) Peripheral blood and granuloma CD4+CD28-T cells are a major source of interferon-γ and tumor necrosis factor-α in Wegener’s granulomatosis. Am. J. Pathol. 160, 1717-1724. <https://doi.org/10.1016/S0002-9440(10)61118-2>
28. Lamprecht, P. (2005) Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin. Exp. Immunol. 141, 201-210. <https://doi.org/10.1111/j.1365-2249.2005.02808.x>
29. Lamprecht, P., Bruehl, H., Erdmann, A., Holl-Ulrich, K., Csernok, E. Seitzer, U., Mack, M., Feller, A. C., Reinhold-Keller, E., Gross, W. L., Muller, A. (2003a) Differences in CCR5 expression on peripheral blood CD4+CD28– T-cells and in granulomatous lesions between localized and generalized Wegener’s granulomatosis. Clin. Immunol. 108, 1-7. <https://doi.org/10.1016/S1521-6616(03)00121-9>
30. Lamprecht, P., Erdmann, A., Mueller, A., Csernok, E., Reinhold-Keller, E., Holl-Ulrich, K., Feller, A. C, Bruehl, H., Gross, W. L. (2003b) Heterogeneity of CD4+ and CD8+ memory T cells in localized and generalized Wegener’s granulomatosis. Arthritis Res. Ther. 5, R25-R31. <https://doi.org/10.1186/ar610>
31. Lamprecht, P., Csernok, E., Gross, W. L. (2006) Effector memory T cells as driving force of granuloma formation and autoimmunity in Wegener’s granulomatosis. J. Intern. Med. 260, 187-191. <https://doi.org/10.1111/j.1365-2796.2006.01698.x>
32. Lamprecht, P., Gross, W. L., Kabelitz, D. (2007) T cell alterations and lymphoid neogenesis favoring autoimmunity in Wegener’s granulomatosis. Arthritis Rheum. 56, 1725-1727. <https://doi.org/10.1002/art.22693>
33. Ludviksson, B. R, Sneller, M. C, Chua, K. S, Talar-Williams, C., Langford, C. A., Ehrhardt, R. O., Fauci, A. S., Strober, W. (1998) Active Wegener’s granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J. Immunol. 160, 3602-3609. <https://doi.org/10.4049/jimmunol.160.7.3602>
34. Marinaki, S., Neumann, I., Kälsch, A. I., Grimminger, P., Breedijk, A., Birck, R., Schmitt, W., Waldherr, R., Yard, B. A., van Der Woude, F. J. (2005) Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis. Clin. Exp. Immunol. 140, 181-191. <https://doi.org/10.1111/j.1365-2249.2005.02731.x>
35. Marinaki, S., Kälsch, A. I., Grimminger, P., Breedijk, A., Birck, R., Schmitt, W. H., Weiss, C., van der Woude, F. J., Yard, B. A. (2006) Persistent T cell activation and clinical correlations in patients with ANCA-associated systemic vasculitis. Nephrol. Dial. Transplant. 21, 1825-1832. <https://doi.org/10.1093/ndt/gfl097>
36. Masutani, K., Tokumoto, M., Nakashima, H., Tsuruya, K., Kashiwagi, M., Kudoh, Y., Fukuda, K., Kanai, H., Akahoshi, M., Otsuka, T., Hirakata, H., Iida, M. (2003) Strong polarization toward Th1 immune response in ANCA-associated glomerulonephritis. Clin. Nephrol. 59, 395-405. <https://doi.org/10.5414/CNP59395>
37. Moosig, F., Csernok, E., Wang, G., Gross, W. L. (1998) Costimulatory molecules in Wegener’s granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin. Exp. Immunol. 114, 113-118. <https://doi.org/10.1046/j.1365-2249.1998.00695.x>
38. Morgan, M. D., Harper, L., Williams, J., Savage, C. (2006) Anti-neutrophil cytoplasm-associated glomerulonephritis. J. Am. Soc. Nephrol. 17, 1224-1234. <https://doi.org/10.1681/ASN.2005080882>
39. Mosmann, T. R, Sad, S. (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17, 138-146. <https://doi.org/10.1016/0167-5699(96)80606-2>
40. Müller, A., Trabandt, A., Gloeckner-Hofmann, K., Seitzer, U., Csernok, E., Schönermarck, U., Feller, A. C., Gross, W. L. (2000) Localized Wegener’s granulomatosis: predominance of CD26 and IFN-γ expression. J. Pathol. 192, 113-120. <https://doi.org/10.1002/1096-9896(2000)9999:9999<::AID-PATH656>3.0.CO;2-M>
41. Popa, E. R., Stegeman, C. A., Bos, N. A., Kallenberg, C. G., Cohen Tervaert, J. W. (1999) Differential B-and T-cell activation in Wegener’s granulomatosis. J. Allergy Clin. Immunol. 103, 885-894. <https://doi.org/10.1016/S0091-6749(99)70434-3>
42. Popa, E. R, Franssen, C. F, Limburg, P. C, Huitema, M. G, Kallenberg, C. G. M., Cohen Tervaert, J. W. (2002) In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3-and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase. Arthritis Rheum. 46, 1894-1904. <https://doi.org/10.1002/art.10384>
43. Rasmussen, N., Petersen, J. (1993) Cellular immune responses and pathogenesis in c-ANCA positive vasculitides. J. Autoimmun. 6, 227-236. <https://doi.org/10.1006/jaut.1993.1020>
44. Rulifson, C. R., Sperlin, A. I., Fields, P. E., Fitch, F. W., Bluestone, J. A. (1997) CD28 costimulation promotes the production of Th2 cytokines. J. Immunol. 158, 658-665. <https://doi.org/10.4049/jimmunol.158.2.658>
45. Saiga, K., Tokunaka, K., Ichimura, E., Toyoda, E., Abe, F., Yoshida, M., Furukawa, H., Nose, M., Ono, M. (2006) NK026680, a novel suppressant of dendritic cell function, prevents the development of rapidly progressive glomerulonephritis and perinuclear antineutrophil cytoplasmic antibody in SCG/Kj mice. Arthritis Rheum. 54, 3707-3715. <https://doi.org/10.1002/art.22187>
46. Sakaguchi, S. (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352. <https://doi.org/10.1038/ni1178>
47. Sanders, J. S. F., Stegeman, C. A., Kallenberg, C. G. M. (2003) The Th1 and Th2 paradigm in ANCA-associated vasculitis. Kidney Blood Press Res. 26, 215-220. <https://doi.org/10.1159/000072987>
48. Sanders, J. S., Huitma, M. G., Kallenberg, C. G., Stegeman, C. A. (2006) Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse. Ann. Rheum. Dis. 65, 1484-1489. <https://doi.org/10.1136/ard.2005.046219>
49. Sarraf, P., Sneller, M. C. (2005) Pathogenesis of Wegener’s granulomatosis: current concepts. Expert Rev. Mol. Med. 7, 1-19. <https://doi.org/10.1017/S146239940500921X>
50. Savage, C. O., Harper, L., Adu, D. (1997) Primary systemic vasculitis. Lancet 349, 553-558. <https://doi.org/10.1016/S0140-6736(97)80118-3>
51. Schmitt, W. H., Heesen, C., Csernok, E., Rautman, A., Gross, W. L. (1992) Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener’s granulomatosis. Association with disease activity. Arthritis Rheum. 35, 1088-1096. <https://doi.org/10.1002/art.1780350914>
52. Schmitt, W. H., Hagen, E. C., Neumann, I., Nowack, R., Flores-Suárez, L.F., van der Woude, F. J.; European Vasculitis Study Group (2004) Treatment of refractory Wegener’s granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int. 65, 1440-1448. <https://doi.org/10.1111/j.1523-1755.2004.00534.x>
53. Sinico, R. A, Di Toma, L., Maggiore, U., Bottero, P., Radice, A., Tosoni, C., Grasselli, C., Pavone, L., Gregorini, G., Monti, S., Frassi, M., Vecchio, F., Corace, C., Venegoni, E., Buzio, C. (2005) Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum. 52, 2926-2935. <https://doi.org/10.1002/art.21250>
54. Stegeman, C. A., Cohen Tervaert, J. W, Huitema, M. G., Kallenberg, C. G. M. (1993) Serum markers of T-cell activation in relapses of Wegener’s granulomatosis. Clin. Exp. Immunol. 91, 415-420. <https://doi.org/10.1111/j.1365-2249.1993.tb05918.x>
55. Stegeman, C. A., Tervaert, J. W., Sluiter, W. J., Manson, W. L., de Jong, P. E., Kallenberg, C. G. (1994) Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann. Intern. Med. 120, 12-17. <https://doi.org/10.7326/0003-4819-120-1-199401010-00003>
56. Steiner, K., Moosig, F., Csernok, E., Selleng, K., Gross, W. L., Fleischer, B., Broker, B. M. (2001) Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener’s granulomatosis. Clin. Exp. Immunol. 126, 143-150. <https://doi.org/10.1046/j.1365-2249.2001.01575.x>
57. Syrbe, U., Siveke, J., Hamann, A. (1999) Th1/Th2 subsets, distinct differences in homing and chemokine receptor expression? Springer Semin. Immunopathol. 21, 263-285. <https://doi.org/10.1007/BF00812257>
58. Szabo, S. J., Sullivan, B. M., Peng, S. L., Glimcher, L. H. (2003) Molecular mechanisms regulating Th1 immune responses. Ann. Rev. Immunol. 21, 713-758. <https://doi.org/10.1146/annurev.immunol.21.120601.140942>
59. Tipping, P. G, Kitching, A. R. (2005) Glomerulonephritis, Th1 and Th2: what’s new? Clin. Exp. Immunol. 142, 207-215. <https://doi.org/10.1111/j.1365-2249.2005.02842.x>
60. Vallejo, A. N, Schirmer, M., Weyand, C. M, Goronzy, J. J. (2000) Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways. J. Immunol. 165, 6301-6307. <https://doi.org/10.4049/jimmunol.165.11.6301>
61. van der Geld, Y. M, Huitema, M. G, Franssen, C. F, van der Zee, R., Limburg, P. C., Kallenberg, C. G. (2000) In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener’s granulomatosis (WG). Clin. Exp. Immunol. 122, 504-513. <https://doi.org/10.1046/j.1365-2249.2000.01415.x>
62. van Paassen, P., Cohen Tervaert, J. W., Heeringa, P. (2007) Mechanisms of vasculitis: How pauci-immune is ANCA-associated vasculitis? Nephron Exp. Nephrol. 105, e10-e16. <https://doi.org/10.1159/000096960>
63. Viglietta, V., Baecher-Allan, C., Weiner, H. L., Hafler, D. A. (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. Exp. Med. 199, 971-979. <https://doi.org/10.1084/jem.20031579>
64. Vogt, S., Iking-Konert, C., Hug, F., Andrassy, K., Hansch, G. M. (2003) Shortening of telomeres: Evidence for replicative senescence of T cells derived from patients with Wegener’s granulomatosis. Kidney Int. 63, 2144-2151. <https://doi.org/10.1046/j.1523-1755.2003.00037.x>
65. Wang, G., Hansen, H., Tatsis, E., Csernok, E., Lemke, H., Gross, W. L. (1997) High plasma levels of the soluble form of CD30 activation molecule reflect disease activity in patients with Wegener’s granulomatosis. Am. J. Med. 102, 517-523. <https://doi.org/10.1016/S0002-9343(97)00049-1>
66. Zhou, Y., Giscombe, R., Huang, D., Lefvert, A. K. (2002) Novel genetic association of Wegener’s granulomatosis with the interleukin 10 gene. J. Rheumatol. 29, 317-320.
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive